Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Filings indexed 2,883 across all filing types
Latest filing 2025-12-30 AGM Information
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
关于召开2026年第一次临时股东会的通知
AGM Information Classification · 95% confidence The document is a notice about convening the 2026 first extraordinary general meeting of shareholders for Chongqing Pharmaceutical Holdings Co., Ltd. It includes details about the meeting time, location, voting procedures, agenda items, and proxy authorization. It does not contain any financial statements or results but is an announcement informing shareholders about the meeting and how to participate. The document length is 3375 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, it fits the category of AGM Information (AGM-R), which covers presentations and materials shared during the Annual General Meeting or similar shareholder meetings.
2025-12-30 Chinese
《信息披露管理制度》(2025年12月)
Governance Information Classification · 95% confidence The document is a detailed internal policy titled "Information Disclosure Management System" of a company, outlining the rules, responsibilities, and procedures for information disclosure. It references regulatory laws and stock exchange rules, describes the types of reports (annual, interim, quarterly, and temporary reports), and details the roles of the board, management, and other stakeholders in disclosure. It does not contain actual financial statements or financial results but rather governs the process and compliance of disclosures. This is a governance-related document about internal rules and practices for information disclosure management, not a financial report or announcement. Therefore, it fits best under Governance Information (CGR). The document length and content confirm it is not a brief announcement or a certification, but a comprehensive governance policy.
2025-12-30 Chinese
《关联交易管理制度》(2025年12月)
Governance Information Classification · 95% confidence The document is titled '关联交易管理制度' which translates to 'Related Party Transaction Management System'. It details the company's policies, principles, decision-making procedures, and disclosure requirements regarding related party transactions. The content is regulatory and governance-focused, outlining internal rules and compliance with laws and stock exchange regulations. It does not contain financial statements, audit results, earnings data, or meeting minutes. It is a governance document describing internal control and management practices related to related party transactions. Therefore, it fits best under Governance Information (CGR). The document length (6636 characters) and detailed procedural content support this classification.
2025-12-30 Chinese
《信息披露暂缓与豁免管理制度》(2025年12月)
Governance Information Classification · 95% confidence The document is titled '信息披露暂缓与豁免管理制度' which translates to 'Information Disclosure Delay and Exemption Management System'. It outlines internal policies and procedures for delaying or exempting disclosure of information, including references to regulatory compliance with Chinese securities laws and stock exchange rules. The content is about governance and internal control over information disclosure, not an actual financial report or announcement. It does not contain financial data, earnings, voting results, or any report publication notice. It is a governance-related document detailing company rules and procedures for managing disclosure obligations. Therefore, the most appropriate classification is Governance Information (CGR). The document length is 2497 characters, which is relatively short but contains substantive policy content, not a mere announcement or certification.
2025-12-30 Chinese
关于2025年日常关联交易执行情况及2026年日常关联交易预计的公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement from a company (重药控股股份有限公司) regarding its daily related party transactions executed in 2025 and the expected related party transactions for 2026. It includes extensive financial figures, descriptions of related parties, transaction categories, pricing principles, and approvals by the board and independent directors. The document references compliance with Shenzhen Stock Exchange listing rules and includes board meeting resolutions and independent director opinions. It is not a full annual or interim financial report, nor is it a call transcript, audit report, or earnings release. It is a regulatory announcement about related party transactions, which is a common type of regulatory filing. The document is lengthy and detailed but does not contain comprehensive financial statements or management discussion and analysis typical of annual or interim reports. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-12-30 Chinese
关于拟变更会计师事务所的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the proposed change of the company's accounting firm for the 2025 audit. It details the new and former accounting firms, reasons for the change, communication with the previous auditor, and the approval process including board and audit committee resolutions. It does not contain any audit reports, financial statements, or detailed audit results itself, but rather informs about the change and the procedural steps. The document length is 3015 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document fits the category of Audit Report / Information (AR) as it relates to audit matters but is not a full annual report or audit report itself. However, since it is primarily an announcement about the change of auditor and related procedural information, it is best classified as an Audit Report / Information (AR) filing rather than a Regulatory Filing (RNS) or Report Publication Announcement (RPA). FY 2025
2025-12-30 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.